Skip to main content

Table 1 Technical evaluation of the BGM competitive ELISA

From: Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases

Technical validation step

BGM ELISA

Target

MMP-9 and -12 degradation of biglycan

Lower limit of detection (LDL)

1.54 ng/mL

Dilution recovery of human serum

100% (1:2), 103% (1:4)

Dilution recovery of human plasma

97% (1:2), 99% (1:4)

Dilution recovery of rat serum

107% (1:2), 102% (1:4)

Dilution recovery of rat plasma

89% (1:2)

Dilution recovery of mouse serum

105% (1:2)

Dilution recovery of mouse plasma

97% (1:2)

Intra-assay variation

10%

Inter-assay variation

15%

  1. Percentage dilution recovery and percentage intra/inter variation are indicated as mean values of different samples diluted 1:2 and 1:4 and as mean variation between ten individual determinations of human samples, respectively.